Literature DB >> 21647157

Critical features of FAK-expressing AML bone marrow microenvironment through leukemia stem cell hijacking of mesenchymal stromal cells.

M Despeaux, E Labat, M Gadelorge, N Prade, J Bertrand, C Demur, C Recher, P Bonnevialle, B Payrastre, P Bourin, C Racaud-Sultan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21647157     DOI： 10.1038/leu.2011.145

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.

Authors:  Anindya Chatterjee; Joydeep Ghosh; Baskar Ramdas; Raghuveer Singh Mali; Holly Martin; Michihiro Kobayashi; Sasidhar Vemula; Victor H Canela; Emily R Waskow; Valeria Visconte; Ramon V Tiu; Catherine C Smith; Neil Shah; Kevin D Bunting; H Scott Boswell; Yan Liu; Rebecca J Chan; Reuben Kapur
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

2.  Focal Adhesion Kinase as a Potential Target in AML and MDS.

Authors:  Bing Z Carter; Po Yee Mak; Xiangmeng Wang; Hui Yang; Guillermo Garcia-Manero; Duncan H Mak; Hong Mu; Vivian R Ruvolo; Yihua Qiu; Kevin Coombes; Nianxiang Zhang; Brittany Ragon; David T Weaver; Jonathan A Pachter; Steven Kornblau; Michael Andreeff
Journal:  Mol Cancer Ther       Date:  2017-03-07       Impact factor: 6.261

3.  The regulation of normal and leukemic hematopoietic stem cells by niches.

Authors:  Meng-Meng Huang; Jiang Zhu
Journal:  Cancer Microenviron       Date:  2012-07-22

4.  Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival.

Authors:  Mona G El-Sisi; Sara M Radwan; Alia M Saeed; Hala O El-Mesallamy
Journal:  Mol Cell Biochem       Date:  2021-01-28       Impact factor: 3.396

Review 5.  In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression.

Authors:  Myriam Janeth Salazar-Terreros; Jean-Paul Vernot
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 6.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

7.  Niche-based screening identifies small-molecule inhibitors of leukemia stem cells.

Authors:  Kimberly A Hartwell; Peter G Miller; Siddhartha Mukherjee; Alissa R Kahn; Alison L Stewart; David J Logan; Joseph M Negri; Mildred Duvet; Marcus Järås; Rishi Puram; Vlado Dancik; Fatima Al-Shahrour; Thomas Kindler; Zuzana Tothova; Shrikanta Chattopadhyay; Thomas Hasaka; Rajiv Narayan; Mingji Dai; Christina Huang; Sebastian Shterental; Lisa P Chu; J Erika Haydu; Jae Hung Shieh; David P Steensma; Benito Munoz; Joshua A Bittker; Alykhan F Shamji; Paul A Clemons; Nicola J Tolliday; Anne E Carpenter; D Gary Gilliland; Andrew M Stern; Malcolm A S Moore; David T Scadden; Stuart L Schreiber; Benjamin L Ebert; Todd R Golub
Journal:  Nat Chem Biol       Date:  2013-10-27       Impact factor: 15.040

8.  FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells.

Authors:  Dewen You; Junping Xin; Andrew Volk; Wei Wei; Rachel Schmidt; Gina Scurti; Sucha Nand; Eun-Kyoung Breuer; Paul C Kuo; Peter Breslin; Ameet R Kini; Michael I Nishimura; Nancy J Zeleznik-Le; Jiwang Zhang
Journal:  Cell Rep       Date:  2015-03-19       Impact factor: 9.423

Review 9.  The roles of mesenchymal stem cells in tumor inflammatory microenvironment.

Authors:  Zhao Sun; Shihua Wang; Robert Chunhua Zhao
Journal:  J Hematol Oncol       Date:  2014-02-06       Impact factor: 17.388

10.  The Src homology-2 protein Shb modulates focal adhesion kinase signaling in a BCR-ABL myeloproliferative disorder causing accelerated progression of disease.

Authors:  Karin Gustafsson; Maria Jamalpour; Camilla Trinh; Michael G Kharas; Michael Welsh
Journal:  J Hematol Oncol       Date:  2014-06-21       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.